These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20829819)

  • 21. Natural Products and Derivatives Targeting at Cancer Energy Metabolism: A Potential Treatment Strategy.
    Wang QQ; Li MX; Li C; Gu XX; Zheng MZ; Chen LX; Li H
    Curr Med Sci; 2020 Apr; 40(2):205-217. PubMed ID: 32337682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer.
    Michelakis ED; Webster L; Mackey JR
    Br J Cancer; 2008 Oct; 99(7):989-94. PubMed ID: 18766181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2010 Keystone Symposium: Metabolism and Cancer Progression.
    DeBerardinis RJ
    Future Oncol; 2010 Jun; 6(6):893-5. PubMed ID: 20528226
    [No Abstract]   [Full Text] [Related]  

  • 24. Q&A: Cancer: clues from cell metabolism.
    Kaelin WG; Thompson CB
    Nature; 2010 Jun; 465(7298):562-4. PubMed ID: 20520704
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of phosphometabolites in cell proliferation, energy metabolism, and tumor therapy.
    Mazurek S; Boschek CB; Eigenbrodt E
    J Bioenerg Biomembr; 1997 Aug; 29(4):315-30. PubMed ID: 9387092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticancer strategies based on the metabolic profile of tumor cells: therapeutic targeting of the Warburg effect.
    Chen XS; Li LY; Guan YD; Yang JM; Cheng Y
    Acta Pharmacol Sin; 2016 Aug; 37(8):1013-9. PubMed ID: 27374491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symporters.
    Marchiq I; Pouysségur J
    J Mol Med (Berl); 2016 Feb; 94(2):155-71. PubMed ID: 26099350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting cancer energy metabolism: a potential systemic cure for cancer.
    Kim SY
    Arch Pharm Res; 2019 Feb; 42(2):140-149. PubMed ID: 30656605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncology's "Hockey Stick" Moment for the Cost of Cancer Drugs-The Climate Is About to Change.
    Polite BN; Ratain MJ; Lichter AS
    JAMA Oncol; 2021 Jan; 7(1):25-26. PubMed ID: 33001134
    [No Abstract]   [Full Text] [Related]  

  • 30. Targeting respiratory complex I to prevent the Warburg effect.
    Vatrinet R; Iommarini L; Kurelac I; De Luise M; Gasparre G; Porcelli AM
    Int J Biochem Cell Biol; 2015 Jun; 63():41-5. PubMed ID: 25668477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multi-modality imaging to assess metabolic response to dichloroacetate treatment in tumor models.
    Neveu MA; De Preter G; Joudiou N; Bol A; Brender JR; Saito K; Kishimoto S; Grégoire V; Jordan BF; Krishna MC; Feron O; Gallez B
    Oncotarget; 2016 Dec; 7(49):81741-81749. PubMed ID: 28082726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dichloroacetate increases cell and product yields in hybridoma batch cultures.
    Murray K; Gull K; Dickson AJ
    Biochem Soc Trans; 1995 Nov; 23(4):585S. PubMed ID: 8654770
    [No Abstract]   [Full Text] [Related]  

  • 33. Acidosis-induced metabolic reprogramming in tumor cells enhances the anti-proliferative activity of the PDK inhibitor dichloroacetate.
    Schoonjans CA; Joudiou N; Brusa D; Corbet C; Feron O; Gallez B
    Cancer Lett; 2020 Feb; 470():18-28. PubMed ID: 31812695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
    Amoedo ND; Obre E; Rossignol R
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug pipeline: 1Q12.
    Mak C
    Nat Biotechnol; 2012 May; 30(5):383. PubMed ID: 22565954
    [No Abstract]   [Full Text] [Related]  

  • 36. mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells.
    Pusapati RV; Daemen A; Wilson C; Sandoval W; Gao M; Haley B; Baudy AR; Hatzivassiliou G; Evangelista M; Settleman J
    Cancer Cell; 2016 Apr; 29(4):548-562. PubMed ID: 27052953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging approaches to target tumor metabolism.
    Ross SJ; Critchlow SE
    Curr Opin Pharmacol; 2014 Aug; 17():22-9. PubMed ID: 25048629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An update on therapeutic opportunities offered by cancer glycolytic metabolism.
    Granchi C; Fancelli D; Minutolo F
    Bioorg Med Chem Lett; 2014 Nov; 24(21):4915-25. PubMed ID: 25288186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth industry.
    Lewis R
    Nature; 2004 Mar; 428(6980):348-9. PubMed ID: 15029202
    [No Abstract]   [Full Text] [Related]  

  • 40. 2-Deoxy-D-glucose enhances dichloroacetate antitumor action against Lewis lung carcinoma.
    Pyaskovskaya ON; Kolesnik DL; Fedorchuk AG; Prokhorova IV; Solyanik GI
    Exp Oncol; 2016 Sep; 38(3):176-80. PubMed ID: 27685525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.